Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A

References

• Makrilia, N., Lappa, T., Xyla, V., Nikolaidis, I., Syrigos, K. The role of angiogenesis in solid tumours: an overview. Eur. J. Intern. Med. 2009, 20, 663–671.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353–364.
   PubMed Web of Science ®Google Scholar
• Risau, W., Flamme, I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 1995, 11, 73–91.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P., Jain, R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407, 249–257.
   PubMed Web of Science ®Google Scholar
• Ferrara, N. VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 2000, 11, 617–624.
   PubMed Web of Science ®Google Scholar
• Liang, W.C., Wu, X., Peale, F.V., Lee, C.V., Meng, Y.G., Gutierrez, J., Fu, L., Malik, A.K., Gerber, H.P., Ferrara, N., Fuh, G. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J. Biol. Chem. 2006, 281, 951–961.
   PubMed Web of Science ®Google Scholar
• Wong, M.L., Prawira, A., Kaye, A.H., Hovens, C.M. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas. J. Clin. Neurosci. 2009, 16, 1119–1130.
   PubMed Web of Science ®Google Scholar
• Kräling, B.M., Wiederschain, D.G., Boehm, T., Rehn, M., Mulliken, J.B., Moses, M.A. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J. Cell. Sci. 1999, 112 (Pt 10), 1599–1609.
   PubMed Web of Science ®Google Scholar
• Zhu, W.H., Guo, X., Villaschi, S., Francesco Nicosia, R. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis. Lab. Invest. 2000, 80, 545–555.
   PubMed Web of Science ®Google Scholar
• Gomez, D.E., Alonso, D.F., Yoshiji, H., Thorgeirsson, U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 1997, 74, 111–122.
   PubMed Web of Science ®Google Scholar
• Kumazaki, K., Nakayama, M., Suehara, N., Wada, Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum. Pathol. 2002, 33, 1069–1077.
   PubMed Web of Science ®Google Scholar
• Bryan, D., Walker, K.B., Ferguson, M., Thorpe R. Cytokine gene expression in a murine wound healing model. Cytokine 2005, 31, 429–438.
   PubMed Web of Science ®Google Scholar
• Glinkowska, G., Balan, B., Sommer, E., Demkow, U., Sokolnicka, I., Strzelecka, H., et al. The effect of phenolic compounds of poplar leaves extract on cutaneous angiogenesis reaction induced in mice by human mononuclear leukocytes. Acta Pol. Pharm. 1997, 54, 151–154.
   PubMedGoogle Scholar
• Kimura, Y., Okuda, H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J. Nutr. 2001, 131, 1844–1849.
   PubMed Web of Science ®Google Scholar
• Madge, L.A., Pober, J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J. Biol. Chem. 2000, 275, 15458–15465.
   PubMed Web of Science ®Google Scholar
• Jenett-Siems, K., Weigl, R., Kaloga, M., Schulz, J., Eich, E. Ipobscurines C and D: macrolactam-type indole alkaloids from the seeds of Ipomoea obscura. Phytochemistry 2003, 62, 1257–1263.
   PubMed Web of Science ®Google Scholar
• Paula, A.C., Hayashi, L.S., Freitas, J.C. Anti-inflammatory and antispasmodic activity of Ipomoea imperati (Vahl) Griseb (Convolvulaceae). Braz. J. Med. Biol. Res. 2003, 36, 105–112.
   PubMed Web of Science ®Google Scholar
• Hamsa, T.P., Kuttan, G. Ipomoea obscura (L.) enhances the functions of immunological effector cells, inhibits pro-inflammatory cytokines and nitric oxide production by LPS induced macrophages. Immunopharmacol Immunotoxicol 2008, 16, 1–15.
   Google Scholar
• Takii, T., Kawashima, S., Chiba, T., Hayashi, H., Hayashi, M., Hiroma, H., Kimura, H., Inukai, Y., Shibata, Y., Nagatsu, A., Sakakibara, J., Oomoto, Y., Hirose, K., Onozaki, K. Multiple mechanisms involved in the inhibition of proinflammatory cytokine production from human monocytes by N-(p-coumaroyl)serotonin and its derivatives. Int. Immunopharmacol. 2003, 3, 273–277.
   PubMed Web of Science ®Google Scholar
• Jaffe, E.A., Nachman, R.L., Becker, C.G., Minick, C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52, 2745–2756.
   PubMed Web of Science ®Google Scholar
• Cole, S.P. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother. Pharmacol. 1986, 17, 259–263.
   PubMed Web of Science ®Google Scholar
• Guo, H.B., Lee, I., Kamar, M., Akiyama, S.K., Pierce, M. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res. 2002, 62, 6837–6845.
   PubMed Web of Science ®Google Scholar
• Albini, A., Iwamoto, Y., Kleinman, H.K., Martin, G.R., Aaronson, S.A., Kozlowski, J.M., McEwan, R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47, 3239–3245.
   PubMed Web of Science ®Google Scholar
• Gupta, K., Kshirsagar, S., Chang, L., Schwartz, R., Law, P.Y., Yee, D., Hebbel, R.P. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002, 62, 4491–4498.
   PubMed Web of Science ®Google Scholar
• Zhu, W.H., Nicosia, R.F. The thin prep rat aortic ring assay: a modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 2002, 5, 81–86.
   PubMedGoogle Scholar
• Billings, P.C., Herrick, D.J., Kucich, U., Engelsberg, B.N., Abrams, W.R., Macarak, E.J., Rosenbloom, J., Howard, P.S. Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells. J. Cell. Biochem. 2000, 79, 261–273.
   PubMed Web of Science ®Google Scholar
• Leyon, P.V., Kuttan, G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J. Exp. Clin. Cancer Res. 2003, 22, 77–83.
   PubMed Web of Science ®Google Scholar
• Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126, 131–138.
   PubMed Web of Science ®Google Scholar
• Bhat, T.A., Singh, R.P. Tumor angiogenesis–a potential target in cancer chemoprevention. Food Chem. Toxicol. 2008, 46, 1334–1345.
   PubMed Web of Science ®Google Scholar
• Kojima, T., Chang, J.H., Azar, D.T. Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am. J. Pathol. 2007, 170, 764–773.
   PubMed Web of Science ®Google Scholar
• Nicosia, R.F., Villaschi, S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab. Invest. 1995, 73, 658–666.
   PubMed Web of Science ®Google Scholar
• Cianchi, F., Cuzzocrea, S., Vinci, M.C., Messerini, L., Comin, C.E., Navarra, G., Perigli, G., Centorrino, T., Marzocco, S., Lenzi, E., Battisti, N., Trallori, G., Masini, E. Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Dig. Liver Dis. 2010, 42, 20–27.
   PubMedGoogle Scholar
• Ramjaun, A.R., Hodivala-Dilke, K. The role of cell adhesion pathways in angiogenesis. Int. J. Biochem. Cell Biol. 2009, 41, 521–530.
   PubMed Web of Science ®Google Scholar
• Kawasaki, K., Smith, R.S. Jr, Hsieh, C.M., Sun, J., Chao, J., Liao, J.K., Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol. Cell. Biol. 2003, 23, 5726–5737.
   PubMed Web of Science ®Google Scholar
• Fukumura, D., Jain, R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 1998, 17, 77–89.
   PubMed Web of Science ®Google Scholar
• Adams, R.H., Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8, 464–478.
   PubMed Web of Science ®Google Scholar
• Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., Hanahan, D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2, 737–744.
   PubMed Web of Science ®Google Scholar
• Doanes, A.M., Hegland, D.D., Sethi, R., Kovesdi, I., Bruder, J.T., Finkel, T. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem. Biophys. Res. Commun. 1999, 255, 545–548.
   PubMed Web of Science ®Google Scholar
• Lal, B.K., Varma, S., Pappas, P.J., Hobson, R.W. 2nd, Durán, W.N. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc. Res. 2001, 62, 252–262.
   PubMed Web of Science ®Google Scholar
• Sethi, G., Sung, B., Aggarwal, B.B. TNF: a master switch for inflammation to cancer. Front. Biosci. 2008, 13, 5094–5107.
   PubMed Web of Science ®Google Scholar
• Salgado, R., Vermeulen, P.B., Benoy, I., Weytjens, R., Huget, P., Van Marck, E., Dirix, L.Y. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer 1999, 80, 892–897.
   PubMed Web of Science ®Google Scholar
• Bussolino, F., Ziche, M., Wang, J.M., Alessi, D., Morbidelli, L., Cremona, O., Bosia, A., Marchisio, P.C., Mantovani, A. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J. Clin. Invest. 1991, 87, 986–995.
   PubMed Web of Science ®Google Scholar
• Neville, M.E., Robb, R.J., Popescu, M.C. In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2. Cytokine 2001, 16, 239–250.
   PubMed Web of Science ®Google Scholar